| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.008 |